A Study to Correlate Endometrial Hyperplasia with Ovarian Stromal Change

Soma Ghosh, Sumana Mukherjee, Gautam Bandopadhyay


Background: Endometrial hyperplasia in peri-menopausal age group is frequently encountered as a result of unopposed excess estrogen action, exact source of which is still debatable. Possible source is ovarian stroma. There must be some subtle changes in ovarian stroma to produce excess estrogen in such states. This study was performed to provide new insights into the various patterns of subtle ovarian stromal changes and its relation to morphological alteration of endometrial glands and stroma.

Methods: 62 women in peri-menopausal age group, diagnosed as endometrial hyperplasia on uterine curettage and unresponsive to conventional therapy, treated by total hysterectomy with unilateral/bilateral salpingo-oophorectomy, were chosen randomly. Serial step sections of endometrial biopsies were examined by routine microscopy. Endometrial hyperplasia was classified following the current WHO classification. The sections from the ovary were examined for changes in the ovarian stroma.

Results: Out of the 62 total cases having endometrial hyperplasia, 53 cases (83.5%) had one or more subtle ovarian stromal changes and 9 cases (14.5%) lacked the ovarian stromal changes. Out of the 50 cases without endometrial hyperplasia, only eight had subtle ovarian changes. In the 53 cases, which showed ovarian stromal changes, the changes were found in combination and variable proportions.

Conclusion: Ovarian stromal changes were significantly associated with endometrial hyperplasia.


Endometrium, Hyperplasia, Ovary, Stroma

Full Text:



Scully RE, Poulsen HE, Sobin LH. Uterine corpus. In:

Histological Typing of Female Genital Tract Tumors.

New York: Springer-Verlag 1994:13.

Atunes CM, Strolley PD, Rosenheim NB et al.

Endometrial cancer and estrogen use. Report of a

large case control study. N Engl J Med 1979; 300: 9-13.

Montgomerry BE, Daum GS, Dunton CJ. Endometrial

hyperplasia: A review. Obstet Gynecol Surv 2004; 59:


Kurman RJ, Kaminski PF, Norris HJ. The behaviour

of endometrial hyperplasia. A long-term study of

untreated hyperplasia in 170 women. Cancer 1985;

: 403-12.

Zaino R, Carinelli SG, Ellenson LH. Tumours of the

Uterine Corpus: Epithelial Tumors and Precursors.

Lyon: WHO Press 2014; 125-26.

Epplein M, Reed SD, Lynda F et al. Risk of complex

and atypical endometrial hyperplasia in relation to

anthropometric measures and reproductive history.

Am J Epidemiol 2008; 168: 563-57.

Ricci E, Moroni S, Parazzini F et al. Risk factors for

endometrial hyperplasia: Results from a case-control

study. International Journal of Gynecological Cancer

; 12(3): 257-60.

Cheung AP. Ultrasound and menstrual history in

predicting endometrial hyperplasia in polycystic ovary

syndrome. Obstetrics & Gynecology 2001; 98(2): 325-

Holm NS, Glintborg D, Andersen MS et al. The

prevalence of endometrial hyperplasia and endometrial

cancer in women with polycystic ovary syndrome or

hyperandrogenism. Acta Obstet Gynecol Scand 2012;

(10): 1173-76.

Marshall K. Polycystic ovary syndrome: Clinical

Considerations. Alternative Medicine Review: A Journal

of Clinical Therapeutic 2001; 6(3): 272-92.

Farber M, Facog D, Philip R et al. Hyperthecosis

syndrome. Obstetrics & Gynecology 44(1): 1-157.

Aiman J, Nalick RH, Facog J et al. The origin of androgen

and estrogen in a virilized postmenopausal woman

with bilateral benign cystic teratomas. Obstetrics &

Gynecology1977; 49: 6.

Hayes MC, Scully RE. Stromal luteoma of the ovary: A

clinicopathological analysis of 25 cases. International

Journal of Gynecologic Pathology 1987; 6(4): 297-393.

Sluijmer AV, Heineman MJ, Kondstaal J. Relationship

between ovarian production of estrone, estradiol,

testosterone, androstenedione and ovarian degree of

stromal hyperplasia in postmenopausal women. The

Journal of the North American Menopause Society

; 5(4): 207-10.

Sasano H, Fukunaga M, Rojas M et al. Hyperthecosis

of the ovary. Clinicopathologic study of 19 cases

with immunohistochemical analysis of steroidogenic

enzymes. Int J Gynecol Pathol. 1989; 8: 311-20.

Lawrence MR, Sternberg WH. Partly luteinized theca

cell tumor of the ovary. Cancer 1983; 126: 1697-1704.

Mossman HW, Koering MJ, Ferry D Jr. Cyclic changes of

interstitial gland tissue of the human ovary. American

Journal of Anatomy 1964: 235-55.

Zheleznov BI, Serov VN, Mamaeva GM. Hyperplastic

ovarian processes from the clinico-morphological

aspect. Akush Ginekol (Mosk) 1994; (2): 35-40.


  • There are currently no refbacks.

Copyright (c) 2018 Recent Advances in Pathology & Laboratory Medicine (ISSN: 2454-8642)